Abstract
Kidney transplants are routinely performed at medical centers around the world. Concurrent with improved surgical techniques, a better understanding of the pharmacology involved in the perioperative anesthetic management has led to improved outcomes in these patients. This chapter reviews the perioperative pharmacologic considerations surrounding kidney transplant patients from the viewpoint of the transplant anesthesiologist.
Keywords: Anesthesia, anesthetics, kidney transplantation, narcotics, pharmacology, renal disease.
Current Clinical Pharmacology
Title:Anesthetic Pharmacology for Kidney Transplantation
Volume: 10 Issue: 1
Author(s): Stephen Aniskevich, Sher-Lu Pai and Timothy S. Shine
Affiliation:
Keywords: Anesthesia, anesthetics, kidney transplantation, narcotics, pharmacology, renal disease.
Abstract: Kidney transplants are routinely performed at medical centers around the world. Concurrent with improved surgical techniques, a better understanding of the pharmacology involved in the perioperative anesthetic management has led to improved outcomes in these patients. This chapter reviews the perioperative pharmacologic considerations surrounding kidney transplant patients from the viewpoint of the transplant anesthesiologist.
Export Options
About this article
Cite this article as:
Aniskevich Stephen, Pai Sher-Lu and Shine S. Timothy, Anesthetic Pharmacology for Kidney Transplantation, Current Clinical Pharmacology 2015; 10 (1) . https://dx.doi.org/10.2174/1574884709666140212100059
DOI https://dx.doi.org/10.2174/1574884709666140212100059 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Protective Effects and Mechanisms of Action of Ulinastatin against Cerebral Ischemia-Reperfusion Injury
Current Pharmaceutical Design Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?
Current Cardiology Reviews Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease
Current Medicinal Chemistry Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research Glycaemic Control in Cardiac Surgery Patients: a Double-Edged Sword
Current Vascular Pharmacology microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia
Current Vascular Pharmacology The Therapeutic Applications of Exosomes in Different Types of Diseases: A Review
Current Molecular Medicine Pharmacological and Biological Activities of Xanthones
Anti-Infective Agents in Medicinal Chemistry New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase
Current Protein & Peptide Science “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Current Drug Therapy Bioactivity and Pharmacological Actions of Carbon Monoxide-Releasing Molecules
Current Pharmaceutical Design On the Involvement of Mitochondrial Intermembrane Junctional Complexes in Apoptosis
Current Medicinal Chemistry Role of Nitrosative Stress and Activation of Poly(ADP-ribose) Polymerase-1 in Cardiovascular Failure Associated with Septic and Hemorrhagic Shock
Current Vascular Pharmacology Immune Mechanisms and Novel Pharmacological Therapies of Acute Kidney Injury
Current Drug Targets Urocortins: Take Them to Heart
Current Medicinal Chemistry - Cardiovascular & Hematological Agents 4-Methylumbelliferones Analogues as Anticancer Agents: Synthesis and in Cell Pharmacological Studies
Anti-Cancer Agents in Medicinal Chemistry Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design Mechanism-Based Inhibitors from Phytomedicine: Risks of Hepatotoxicity and their Potential Hepatotoxic Substructures
Current Drug Metabolism Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery
Current Pharmaceutical Design